Skip to main content
Alzheimer's Research & Therapy logoLink to Alzheimer's Research & Therapy
. 2022 Jan 20;14:13. doi: 10.1186/s13195-022-00960-6

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Jun Pyo Kim 1,2, Bo-Hyun Kim 3, Paula J Bice 1, Sang Won Seo 4, David A Bennett 5, Andrew J Saykin 1,6,7,, Kwangsik Nho 1,6,; for the Alzheimer’s Disease Neuroimaging Initiative
PMCID: PMC8780731  PMID: 35057845

Correction to: Alzheimers Res Ther 13, 164 (2021)

https://doi.org/10.1186/s13195-021-00906-4

Following the publication of the original article [1] the authors noticed that an 8 was inserted between CS and F of the word CSF in the article title. The correct article title should be:

BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease”

The original article [1] has been updated.

Contributor Information

Andrew J. Saykin, Email: asaykin@iu.edu

Kwangsik Nho, Email: knho@iupui.edu.

Reference

  • 1.Kim JP, Kim BH, Bice PJ, et al. BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease. Alzheimers Res Ther. 2021;13:164. doi: 10.1186/s13195-021-00906-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Alzheimer's Research & Therapy are provided here courtesy of BMC

RESOURCES